Table 1 Clinical characteristics of 1453 patients
Value | ||
|---|---|---|
Characteristics a | No. (%) | Median (P25, P75) /Average (SD) |
Patients | 1453 | |
Infants (< 2yrs) | 139(9.57%) | |
Children (2 to 12yrs) | 1071(73.71%) | |
Adolescents (12 to 18yrs) | 243(16.72%) | |
Samples | 1453 | |
Sex (male) | 867(59.67%) | |
Age (yrs) | 6.7(3.7, 10.7) | |
Weight (kg) | 21.7(15, 34.5) | |
BMI (kg/m2) | 15.91(14.42, 17.88) | |
ALB (g/L) | 38.85(0.11) | |
ALT (U/L) | 25.1(14.6, 45.8) | |
AST (U/L) | 24.6(17, 36.75) | |
ALP (U/L) | 122(92, 163.05) | |
GTT (U/L) | 24.2(15.5, 50.55) | |
TBIL (µmol/L) | 10.7(7.30, 15, 71) | |
DBIL (µmol/L) | 4.24(2.82, 6.63) | |
IBIL (µmol/L) | 6.3(4.32, 9.14) | |
BUN (mmol/L) | 3.69(2.73, 4.85) | |
SCR (µmol/L) | 25.4(19.65, 33.7) | |
LDH (U/L) | 220.6(174, 310.95) | |
WBC (*10^9/L) | 0.75(0.07, 2.47) | |
NE (*10^9/L) | 0.1(0.00, 0.95) | |
HLB (g/L) | 78(69, 89) | |
PLT (*10^9/L) | 44(24, 86) | |
eGFR | 169.85(137.11, 207.31) | |
Hematologic malignancy type | ||
Acute lymphoblastic leukemia | 594(40.88%) | |
Acute non-lymphocytic leukemia | 444(30.56%) | |
lymphoma | 48(3.3%) | |
Aplastic anemia | 212(14.59%) | |
other | 155(10.67%) | |
Vancomycin dose(mg/kg/day) | 39.6(37.5, 42.36) | |
Vancomycin trough concentration (mg/L) | 5.3(3.5, 8.3) | |